In clinical trials of ADHD, weight loss occurred in: 3% to 4% of adults who took Vyvanse 9% of children who took Vyvanse 0% to 1% of adults and children who took a placebo (treatment containing no active drug) After 4 weeks of treatment, the average weight loss in people who took Vyvanse was: 2.8 pounds (lb) to 4.3 lb (1.3 kilograms [kg] to 2 kg) in adults 2.7 lb to 4.8 lb (1.2 kg to 2.2 kg) in children ages 13 to 17 years 0.9 lb to 2.5 lb (0.4 kg to 1.1 kg) in children ages 6 to 12 years The amount of weight lost depended on dose, with more weight loss seen in people who took higher doses of Vyvanse
May 13, 2026: New Jersey-Based Litigations Advancing While much of the attention is on the Ozempic MDLs, don't forget that many other cases are also active in New Jersey state court
1 ottobre 2019 [citato 5 giugno 2024];257:7748
Remove any air bubbles by tapping the syringe and gently pushing the plunger until a tiny drop appears at the needle tip
Beyond VA healthcare, other government programs like TRICARE have different coverage rules: TRICARE covers Zepbound for long-term weight management, but there are requirements: You must have a BMI of 30 or higher (or 27 or higher with a weight-related condition like OSA or high blood pressure)
Patients should discuss all medications and supplements with their healthcare provider
